Official Name: Merck & Co., Inc.

Headquarters: Kenilworth, NJ, United States

Founded: 1891

Employees: 67,000

CEO: Mr. Robert M. Davis J.D.

NYSE: MRK -0.94%

Market Cap

$318.75 Billion

USD as of July 1, 2024

Market Cap History

Company Description

Merck & Company, Inc., known as Merck Sharp & Dohme, or MSD, outside the United States and Canada, is one of the largest pharmaceutical companies in the world. Founded in 1891 in the US, and independent since World War I from its parent company, now one of the largest companies in Germany, Merck provides prescription medicines, vaccines, biologic therapies, and animal health products.

Merck market capitalization over time

Evolution of Merck & Co., Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Merck & Co., Inc.

Detailed Description

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Top 1-year algo backtest: +191.38%

$10,000 in June 2023 would now be $29,138 by following this algorithm daily at market close.

Boost your returns with Disfold DeepFinance... Now!

Try Disfold DeepFinance FREE

Stocks & Indices

Merck & Co., Inc. has the following listings and related stock indices.

Stock: NYSE: MRK wb_incandescent

Stock: FSX: 6MK wb_incandescent

Stock: Euronext: MRK wb_incandescent

Product & Services

Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)

Key People

Founder(s): Theodore Weicker George Merck

Kenneth C. Frazier (Executive Chairman) Robert M. Davis (President and CEO)


Revenue: US$47.994 billion (2020)

Operating income: US$8.791 billion (2020)

Net income: US$7.067 billion (2020)

Total assets: US$89.800 billion (2020)

Total equity: US$29.270 billion (2020)



2000 Galloping Hill Road

Kenilworth, NJ 07033

United States

Phone: 908 740 4000